Indolequinone-Based Hypoxia-Activated Proteolysis Targeting Chimeras Selectively Degrade BRD4 in Hypoxic Cancer Cells

Journal:

Journal of the American Chemical Society

Published:

2025-09-24

DOI:

10.1021/jacs.5c10240

Affiliations:

6

Authors:

8

Go to article

Institutions	Authors	Share
University of Oxford, United Kingdom (UK)	7.200000	0.90
University of California, Los Angeles (UCLA), United States of America (USA)	0.400000	0.05
California NanoSystems Institute (CNSI), United States of America (USA)	0.200000	0.03
UCLA Jonsson Comprehensive Cancer Center, United States of America (USA)	0.200000	0.03

Interested in Pharmacology and Pharmaceutical Sciences?